Pharma News - Chemdiv

Novartis faces threat of early generic of MS drug Gilenya in US

Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. ...

Enanta lawsuit claims Pfizer’s Paxlovid infringes its patent

S biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant. ...

AbbVie files Qulipta for chronic migraine prevention

AbbVie has filed for approval of its oral CGRP inhibitor Qulipta for prevention of chronic migraine, seeking to leap ahead of its main rival in the class.

U.S. FDA Approves Merck’s Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Vaxneuvance™(Pneumoc...

Paratek Pharma Shares Rise After Nuzyra Gets FDA Fast Track

Shares of Paratek Pharmaceuticals Inc. were trading higher in Tuesday's after-hours market, following news the U.S. Food and Drug Administration granted Fast Track designation for the oral and IV ...

Is Merck planning a $30bn-plus move for Seagen?

Speculation that Merck & Co may be preparing a $30 billion takeover bid for Seagen – bolstering its oncology ambitions – has the biopharma community aflutter. ...

AZ preps FDA filing for $3.6bn amyloidosis drug eplontersen

Armed with new phase 3 data, AstraZeneca is preparing to file for regulatory approval of eplontersen, an antisense drug for one of the complications of the disease transthyretin amyloidosis (ATTR) ...

Clovis Abandons Previous FDA Approval of Rubraca Following Study Data

Clovis Oncology has requested a withdrawal of FDA approval of Rubraca (rucaparib) for treating patients with BRCA-mutated ovarian cancer after two or more chemotherapies. ...

Experimental Drug Developed In Sweden Could Revolutionize Diabetes Treatment For Four Million Britons

A new type of drug that prompts the body’s muscles to absorb excess blood sugar could revolutionize the treatment of type 2 diabetes.

Nuvectis Pharma Announces FDA Clearance of IND for NXP800

Nuvectis Pharma, Inc., a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today ann...

NICE Recommends Eli Lilly’s Verzenios for Early Breast Cancer

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Eli Lilly’s Verzenios (abemaciclib) for National Health Service (NHS) use in patients with hormone receptor-po...

Similarities between Alzheimer’s and long COVID found in new study

New research led by scientists from Australia’s La Trobe University suggests proteins generated by the SARS-CoV-2 virus can form into aggregations similar to those found in the brains of patients...